Dr. Michael Nili is a neuropathologist and an expert in the field of disease modeling. Dr. Nili is the first scientist to discover the role of the role of supplementing cellular glutathione in order to strengthen the cell's immune response. Dr. Nili's discovery has been applied to numerous immunological studies to successfully combat viral/bacterial infections as well as chronic maladies such as cancer and degenerative disorders. Dr. Nili holds degrees in Psychopathology, Neurobiology and Neuropathology as well as laboratory experience in Pathology, Radiation Physics, Biopathology, Radiation Biology, Health Physics, Antioxidant Therapy, Radiotherapy, Interaction between Neurophysiology and Radiation, Neuropathology, Medical Dosimetry, Radiation Protection. Dr. Nili has advanced the field on neuropathology through his work on antioxidant therapy by demonstrating the protective activity of N-acetyl-L-cysteine (NAC) against cellular oxidative stress induced by radiation. Dr. Nili has further analyzed the radioresponse of human lymphocytes pretreated with boron and gadolinium as assessed by the comet assay. Dr. Nili has publish numerous international science articles as well as presented his research in over 64 countries worldwide. Dr. Nili complete his research training work at Harvard Medical Schools where he also served as a medical school instructor. Dr. Michael A. Nili has conducted research associated with a number of other international organizations and is currently serving as a Scientific Advisor in Geneva, Switzerland.
|
